Condition: Diagnostics · Pandemic Response · Sponsor: Istituto Zooprofilattico Sperimentale delle Venezie
In the case of large emergency serosurveys, innovation in the sampling techniques is an often neglected, but relevant aspect to facilitate the enrolment of subjects in both adult and paediatric populations. Further, neutralization assays are the first line of response immediately after the emergence of a novel virus in the human population. This study aims at developing at IZSVe 384-format high-throughput neutralization assays for emerging and re-emerging respiratory viruses with pandemic potential to increase the preparedness capacity at both regional and national levels. This diagnostic platform will include the validation of Mitra VAMS devices for gathering blood samples for the diagnostic procedure. The platform will be tested and validated using adult subject-matched serum samples collected by venipuncture and finger-prick with volumetric tip microsampling devices (Mitra VAMS). This comparison will focus on the titration of antibodies against endemic viruses like influenza type A (i.e., seasonal influenza strains, like pdmH1N1 or H3N2) and SARS-CoV-2. The same serological assay will be developed to titrate neutralizing antibodies against emerging pathogens like avian influenza viruses of the H3 and H5 subtypes, Zika virus, and MERS-CoV.
This description comes directly from the study's public registry record.
Head of the Laboratory of Experimental Animal Models IZSVe · +39 049 8084101-102 · fbonfante@izsvenezie.it
Olga S Munoz Pogoreltseva, DVM, MSc, PhD in Public Health · +39 049 8084101-102 · omunoz@izsvenezie.it
Always discuss trial participation with your own doctor first.
| Istituto Zooprofilattico Sperimentale delle Venezie | Padova, Italy, Italy | Recruiting |
| Padova University Hospital, Department of Women's and Children's Health | Padova, Italy, Italy | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06939556